{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:45:54Z","timestamp":1762854354035,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.gofs.2021.03.011","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T10:57:12Z","timestamp":1618570632000},"page":"318-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment diagnostiquer la m\u00e9nopause\u00a0? RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi"],"prefix":"10.1016","volume":"49","author":[{"given":"C.","family":"Rousset-Jablonski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gofs.2021.03.011_bib0225","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.fertnstert.2012.01.128","article-title":"Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging","volume":"97","author":"Harlow","year":"2012","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.011_bib0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016\u00a0IMS Recommendations on women's midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.011_bib0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/13697130701258838","article-title":"Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging","volume":"10","author":"Harlow","year":"2007","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.011_bib0240","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/jc.2002-020777","article-title":"Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status","volume":"88","author":"Randolph","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.011_bib0245","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1210\/jc.2010-1746","article-title":"Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period","volume":"96","author":"Randolph","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.011_bib0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.fertnstert.2006.05.074","article-title":"Association of anti-mullerian hormone levels with obesity in late reproductive-age women","volume":"87","author":"Freeman","year":"2007","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.011_bib0255","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/01.gme.0000172268.24949.94","article-title":"The relationship between obesity and race on inhibin B during the menopause transition","volume":"12","author":"Gracia","year":"2005","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.011_bib0260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajog.2009.12.020","article-title":"Racial and ethnic disparities in reproductive endocrinology and infertility","volume":"202","author":"Huddleston","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.011_bib0265","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2105\/AJPH.2005.066936","article-title":"Longitudinal analysis of the association between vasomotor symptoms and race\/ethnicity across the menopausal transition: study of women's health across the nation","volume":"96","author":"Gold","year":"2006","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.011_bib0270","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.011_bib0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.gme.0000198489.49618.96","article-title":"Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)*","volume":"13","author":"Henrich","year":"2006","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.011_bib0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2013.07.009","article-title":"Contraception during the periMenopause","volume":"76","author":"Baldwin","year":"2013","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.011_bib0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0015-0282(16)58394-0","article-title":"Laboratory criteria for menopause in women using oral contraceptives","volume":"66","author":"Creinin","year":"1996","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.011_bib0290","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0010-7824(95)00229-4","article-title":"When is it safe to switch from oral contraceptives to hormonal replacement therapy?","volume":"52","author":"Castracane","year":"1995","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.011_bib0295","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.011_bib0300","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/humrep\/dev197","article-title":"Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan","volume":"30","author":"Birch Petersen","year":"2015","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.011_bib0305","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.fertnstert.2005.10.036","article-title":"Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges","volume":"85","author":"Gelbaya","year":"2006","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.011_bib0310","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/humrep\/dem105","article-title":"Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy","volume":"22","author":"Hehenkamp","year":"2007","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.011_bib0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jmig.2009.10.001","article-title":"Controlled clinical trial assessing the effect of laparoscopic uterine arterial occlusion on ovarian reserve","volume":"17","author":"Qu","year":"2010","journal-title":"J Minim Invasive Gynecol"},{"issue":"32","key":"10.1016\/j.gofs.2021.03.011_bib0320","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1200\/JCO.2009.22.8312","article-title":"Fertility Preservation in Adolescents and Young Adults With Cancer","volume":"28","author":"Levine","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.011_bib0325","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2012.43.5511","article-title":"Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications","volume":"31","author":"Metzger","year":"2013","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.gofs.2021.03.011_bib0330","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.011_bib0335","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2006-0020","article-title":"Acute ovarian failure in the childhood cancer survivor study","volume":"91","author":"Chemaitilly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.011_bib0340","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.011_bib0345","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/jc.2011-1038","article-title":"Resumption of ovarian function and pregnancies in 358\u00a0patients with premature ovarian failure","volume":"96","author":"Bidet","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"10.1016\/j.gofs.2021.03.011_bib0350","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cncr.25106","article-title":"Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study","volume":"116","author":"Sukumvanich","year":"2010","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.011_bib0355","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/humrep\/del201","article-title":"The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer","volume":"21","author":"Anderson","year":"2006","journal-title":"Hum Reprod"},{"issue":"14","key":"10.1016\/j.gofs.2021.03.011_bib0360","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ejca.2014.06.011","article-title":"A highly-sensitive anti-M\u00fcllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer","volume":"50","author":"Chai","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gofs.2021.03.011_bib0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-M\u00fcllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2021.03.011_bib0370","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1530\/EC-18-0180","article-title":"Post-chemotherapy serum anti-M\u00fcllerian hormone level predicts ovarian function recovery","volume":"7","author":"Kim","year":"2018","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.011_bib0375","doi-asserted-by":"crossref","first-page":"e66616","DOI":"10.1371\/journal.pone.0066616","article-title":"Tamoxifen and ovarian function","volume":"8","author":"Berliere","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.011_bib0380","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1210\/jc.2002-021516","article-title":"Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition","volume":"88","author":"Welt","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.011_bib0385","doi-asserted-by":"crossref","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN Guidelines Insights: Breast Cancer, Version 1.2017","volume":"15","author":"Gradishar","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"10001","key":"10.1016\/j.gofs.2021.03.011_bib0390","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.011_bib0395","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1200\/JCO.2011.36.8993","article-title":"Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group","volume":"30","author":"Dubsky","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.011_bib0400","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.gofs.2021.03.011_bib0405","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1200\/JCO.2006.08.8054","article-title":"Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95\u00a0Study","volume":"25","author":"Kaufmann","year":"2007","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.011_bib0410","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.ejca.2012.12.025","article-title":"Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: long term results of the Italian Tamoxifen Anastrozole trial","volume":"49","author":"Boccardo","year":"2013","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1016\/j.gofs.2021.03.011_bib0415","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1200\/JCO.2015.62.2985","article-title":"Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole","volume":"34","author":"Krekow","year":"2016","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.011_bib0420","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx074","article-title":"Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure","volume":"109","author":"van Hellemond","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.011_bib0425","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/annonc\/mds464","article-title":"Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane","volume":"24","author":"Guerrero","year":"2013","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2021.03.011_bib0430","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/annonc\/mdt149","article-title":"Predictors of recovery of ovarian function during aromatase inhibitor therapy","volume":"24","author":"Henry","year":"2013","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.011_bib0435","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/gme.0b013e318204af88","article-title":"Undetectable antim\u00fcllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor","volume":"18","author":"Dieudonn\u00e9","year":"2011","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.011_bib0440","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.fertnstert.2010.12.005","article-title":"Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors","volume":"95","author":"Su","year":"2011","journal-title":"Fertil Steril"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246871892100060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246871892100060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:40:57Z","timestamp":1762854057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246871892100060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S246871892100060X"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.011","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment diagnostiquer la m\u00e9nopause\u00a0? RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}